FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

32473711000001107: Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
98717401000001111 Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
98717501000001110 Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Is a Varenicline 1mg tablets and Varenicline 500microgram tablets true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has active ingredient Varenicline true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Is a Champix true Inferred relationship Existential restriction modifier
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) 53 tablet 1x(11+14tablets)+1x(28tablets) Has AMP True Champix 0.5mg/1mg 4 week treatment initiation pack (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start